![F. Carsten Thiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
F. Carsten Thiel
Amministratore Delegato presso
EUSA Pharma (UK) Ltd.
Profilo
F.
Carsten Thiel is currently the Chief Executive Officer & Director at EUSA Pharma (UK) Ltd. He was previously the Chief Executive Officer & Director at Abeona Therapeutics, Inc. for a brief period in 2018.
He also served as the Chief Executive Officer at AMGEN GmbH and as a Director at Karyopharm Therapeutics, Inc. He was the Vice President & Head-Europe at Amgen, Inc. from 2011 to 2014 and the Executive VP & Chief Commercial Officer at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
Dr. Thiel holds a doctorate degree from Max-Planck-Institute for Molecular Genetics and a graduate degree from Philipps University of Marburg.
Posizioni attive di F. Carsten Thiel
| Società | Posizione | Inizio |
|---|---|---|
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Amministratore Delegato | 31/03/2021 |
Precedenti posizioni note di F. Carsten Thiel
| Società | Posizione | Fine |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Direttore/Membro del Consiglio | 27/11/2018 |
| ABEONA THERAPEUTICS INC. | Amministratore Delegato | 26/11/2018 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2014 |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Amministratore Delegato | - |
Formazione di F. Carsten Thiel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
AMGEN GmbH
AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Health Technology |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Distribution Services |
